Skip to content

Remote Programming of Cardiac Implantable Electronic Devices 2

Remote Programming of Cardiac Implantable Electronic Devices 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06272344
Acronym
REACT 2
Enrollment
36
Registered
2024-02-22
Start date
2023-04-24
Completion date
2024-04-02
Last updated
2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Defibrillator, Pacemaker, Telemedecine

Keywords

Implantable cardioverter defibrillator, ICD, Telemedecine, Remote monitoring, Remote programming, Cardiac implantable electronical device, Medically underserved population, Medically underserved area, Health professional shortage area

Brief summary

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators need to be regularly and systematically interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full CIED check-up and reprogramming is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. The aim of this study is to evaluate our previously validated remote programming solution (REACT study, NCT05366660) in outpatient device clinics which are close to the patient's home but remote from the CIED expert.

Detailed description

Remote programming of a CIED offers multiple advantages such as shorter travel distances for the patient, reduced need for presence of specialized cardiologists and the possibility to offer expert support at remote locations or developing countries. Remote programming may be a way to mitigate disparities in health care access. The remote surveillance centre of CHU Bordeaux has previously developed and validated (REACT study, NCT05366660) a remote control system for CIED programmers that eliminates the physical presence of a cardiologist during the interrogation and programming process. The aim of this study is to evaluate this solution for the remote evaluation of CIEDs at the benefit of inhabitant of medically underserved population. Enrolled patients living \>100km from the Bordeaux University Hospital will undergo there an in person evaluation of their CIED which will be compared six months later with a remote evaluation in a nurse office close to the patient's home.

Interventions

OTHERTeleconsultation

Teleconsultation at 6 months

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Prospective, single-center, single-arm, pairwise comparison trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient of both sexes over the age of 18 * Patients implanted with a cardiac pacemaker or an automatic defibrillator and an indication for device check-up (interrogation ± programming) * Patient followed at the Bordeaux University Hospital but living more than 90km away * Person beneficiary of social security insurance * Informed consent confirmed in writing (at the latest on the day of inclusion and before any examination required by the research) * Women of procreating age with effective contraception

Exclusion criteria

* Patients younger than 18 years old * Patients who are incapable to understand the study design or to give informed consent. * Pregnant or breastfeeding women * Persons placed under legal protection * Subject deprived of liberty on judicial or administrative decision * Persons participating in another study who are still in their period of exclusion

Design outcomes

Primary

MeasureTime frameDescription
assess the satisfaction of patients benefiting from a teleconsultation compared to a standard consultation at hospital6 monthsPatient satisfaction

Secondary

MeasureTime frameDescription
Time saving for patient6 monthsTime of consultation and teleconsultation
Savings on medical transport6 monthsCost of medical transports for consultation and teleconsultation
Costs associated with teleconsultation6 monthsGlobal amount of costs for teleconsultation
safety of teleconsultation6 monthsNumber of Adverse Events and technical incidents

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026